Abstract
The first cases of mucocutaneous lymph node syndrome (MLNS) were reported by Dr Tomisaku Kawasaki in 1967. His surname was later assigned to this new disease entity, and I was fortunate to meet him at the 100 Annual Conference of the German Paediatric Association in Berlin in 2004 [1]. According to our current understanding Kawasaki disease (KD) is a systemic autoimmune vasculitis which occurs in genetically susceptible people following an acute infection. Outside Japan KD has a low incidence and is notoriously difficult to diagnose because of its similarity to common infective childhood illnesses and a lack of specific and sensitive laboratory tests. The case report of KD by Bangert et al. [2] illustrates these difficulties aptly and calls for prompt diagnosis and treatment of this condition to avoid serious cardiovascular complications.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
